Biosafety/Biosecurity: An Update February 27, 2004.

Slides:



Advertisements
Similar presentations
Emergency Preparedness and Response
Advertisements

Security Training For Select Agent Laboratories Applicable Regulations 42 CFR Part 73 (DHHS) 9 CFR 121 (APHIS) 7 CFR 331 (APHIS)
Outline Introduction to the National Institutes of Health Office of Biotechnology Activities History and Evolution of IBCs: Asilomar to the Present Overview.
Mount Sinai School of Medicine Select Agents Training Philip G. Hauck, MS, MSHS, CIH, CBSP, SM(NRCM) 10/2012 Edition.
Responsible Conduct of Research & Research Compliance Adam J. Rubenstein, Ph.D. Director of Research Compliance Old Dominion University Office of Research.
Suzanne Reister, Program Manager Paula Vanderpool, Program Assistant North Central Washington Workers’ Comp Trust Chemical Hygiene – Hazardous Chemicals.
1 Recent Bioterrorism Legislation Madelyn Miller August 2003.
Office of Research Oversight. Working Group Report Slide 2.
Biological and Radiological Regulatory Concerns for Research Administrators Megan G. Marks, Ph.D. Biological and Radiological Safety Manager Carnegie Mellon.
BJH-WU Research Transition Washington University Environmental Health & Safety.
Biosafety Program Development Presented by: Lisa Wisser, CIH AIHCE - June 6, 2001.
Office of the Vice President for Research
Principles and Practices of Biosafety Environmental Health and Safety San Diego State University.
1 NOTES This presentation is an outline of some of the most important aspects of DOE O 440.1B For completeness, copies of the Order should accompany this.
Developing a Chemical Risk Management Program
Environmental Health and Safety Radiation Control and Radiological Services.
ERIKA BARRETT TECHNICIAN, BIOLOGICAL SAFETY OFFICE OF RADIATION, CHEMICAL & BIOLOGICAL SAFETY FRIDAY, OCTOBER 3.
Health and Safety Awareness Low Risk Areas Lawrence Dickson Training and Audit Co-ordinator Health and Safety Department.
Research and Biological Safety Office Environmental Health and Safety
Safety Review and Approval Process for Research Proposals Robert Emery, DrPH, CHP, CIH, CBSP, CSP, CHMM, CPP, ARM Vice President for Safety, Health, Environment.
CUI Statistical: Collaborative Efforts of Federal Statistical Agencies Eve Powell-Griner National Center for Health Statistics.
NC A&T STATE UNIVERSITY
1 Lawrence Berkeley National Laboratory Integrated Safety Management Systems Review August 8-9, 2006 B erkeley Lab Safety Committee Presentation Paul Blodgett.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Laboratory Biorisk Management Standard CWA 15793:2008
Introduction to the MUSC Institutional Biosafety Committee (IBC) Registration Process Daniel Eisenman, PhD MUSC Biosafety Officer
Research Protocol Registration at WUStL Institutional Biological and Chemical Safety Committee/ Environmental Health and Safety Joe Kanabrocki Biological.
IACUC and IBC PROCESS. Office of Research Services Resource Center Building Room Kenneth Kratz, PhD –Director Staff: Nicole Barron – Pre-award.
Responsible Conduct of Research (RCR) Farida Lada October 16, 2013
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
CITI Biosafety Training Information Project
INSTITUTIONAL REVIEW OF BIOSAFETY RESEARCH Review of Institutional Biosafety Committee Application Form Robert J. Hashimoto The University of Kentucky.
Safety. Four Simple Questions What are the hazards? What are the hazards? What are the worst things that could happen? What are the worst things that.
Biosafety/ Biosecurity in Georgia Lela Bakanidze, Ph.D. National Center for Disease Control and Medical Statistics of Georgia Scientific Networking and.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
Research Compliance: An Overview of the Players and Issues Involved in Emory’s Research Compliance Programs.
Animal Research at Princeton Prepared by Stuart Leland Director, Research Integrity and Assurance For use and distribution by the Princeton University.
Biosecurity at CDC pre & post 9/11 Jonathan Y. Richmond, PhD Director Office of Health and Safety CDC, Atlanta.
Human Research Protection Program & IRB Responsibilities Marisue Cody, PhD Director Center on Advice & Compliance Help.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Regulatory Authority.
Office of Research Oversight 1 ORO Research Suspensions and Other ACOS/R Concerns Tom Puglisi, PhD Local Accountability in Research April 8, 2010.
Deona Willes, Basic Steps for New LabsBasic Steps for New Labs  Complete forms for protocol review and submit chemical inventory.
Tulane University - Office of Environmental Health & Safety (OEHS) Environmental Health & Safety Compliance Management System & Departmental Safety Representative.
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Inspection Part III.
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
Office of Human Research Protection Georgia Health Sciences University.
R EGULATORY A GENCIES What are regulatory issues? Types of agencies How they affect you Top 10 regulatory issues.
INTERNATIONAL SCIENCE AND ENGINEERING FAIR Rules and Guidelines 2016.
1 Research & Development Committee Brenda Cuccherini, Ph.D., MPH Office of Research & Development January 2007.
Office of Research Oversight What’s New in VHA Handbook Dated November 15, 2011 December 1, 2011.
Research Policy: ORD & ORO Working Together Brenda Cuccherini, PhD Office of Research & Development & Tom Puglisi, PhD Office of Research Oversight.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
The IBC is: The Institutional Biosafety Committee (aka Biohazards Committee)
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Program Performance Criteria.
Regulatory Agencies What are regulatory issues? Types of agencies How they affect you Top 10 regulatory issues.
NC A&T STATE UNIVERSITY
Biosafety at Swinburne
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
Randall (Randy) Snyder, PT, MBA Division Director January 27, 2016
Office of Animal Welfare Assurance (OAWA) Janna Barcelo, BA, CPIA
ROLE OF THE INSTITUTIONAL BIOSAFETY COMMITTEE
Training Requirements for PI and Research Staff
Office of Animal Care Compliance (OACC)
Allen Chan U.S. Government Accountability Office October 2, 2018
Emergency Preparedness Requirements
Whose Job Is It? Responsibility for Laboratory Safety and Security
Lodi Unified School District Safety & Security
OSU Controlled Substances Training Module for Researchers
Presentation transcript:

Biosafety/Biosecurity: An Update February 27, 2004

Where is the emphasis? Biosafety   Biosecurity

Biosafety Policy –Handbook “Safety of Personnel Engaged in Research” –VA Directive 7701 & Handbook “Occupational Safety & Health” –OSHA’s regulations Plans –Minor updates to –Revise biosafety form ( ) –Define training needs

Role for Research Biosafety Ensure safety of personnel Identify hazards: chemical, physical, and biological Incorporate into VAMC wide occupational safety program, fire safety, PPE and precautions Safety & health inspections: local, VA CO, or others Policies, plans and procedures

Hazard Categories Chemical: corrosive, toxins, carcinogens, mutagens, flammables, explosive Physical: ionizing and non-ionizing radiation, noise, temperature extremes, electrical mechanical Biological: pathogens, organism, recombinant DNA, toxins produced by organisms and human or animal tissue, body secretions, & blood

Biosecurity An increasing concern Effects all research laboratories Special emphasis on BSL-3s & labs with select agents or toxins Required revising Directive (Control of Hazardous Agents) Draft is unofficial & in concurrence

The Concurrence Process Draft  Concurring Offices  Final Document

Control of Hazardous Agents (Why The Re-draft) Approach: –Facility’s comprehensive program Address concerns of IG Meet new standards –HHS (CDC) –USDA (APHIS) Clarify current requirements

Control of Hazardous Agents Program A unified approach Integrates: –VAMC safety & security program and –Research safety & security program Medical Center Director (MCD) is responsible institutional official Requires coordination and cooperation of many offices

Definition:Select Agents (SA) & Toxins SA: Group of agents designated by HHS/CDC as requiring registration with CDC lab registration program –Viruses, bacteria, rickettsiae, fungal, toxins, recombinant DNA Biological agents and toxins (USD/APHIS): agents with potential to be severe threat to animal & plant health -- Labs must also register Overlap agents: found in CDC & APHIS lists Directive refers to CDC & APHIS agents collectively as SA & toxins

Definition: Hazardous Agents Hazardous agents include: –Select agents & toxins –Exempt quantities of toxins –Other hazardous chemicals –Radioactive material –Sensitive material List in Directive and draft directive

Control of Hazardous Agents Program (cont) Based on regulatory, scientific & ethical principals Relevant policies and regulations –VHA Research & non-research –HHS/CDC –USDA/APHIS –Dept. of Commerce –Dept. of Transportation –EPA –OSHA

Roles and Responsibilities MCD is the Responsible Official ACOS/AO – Research point of contact –Liaison with VAMC committees, personnel, police etc – Personnel, lab access, resources –Annual assessments and drills –Role with R&D committee/SRS –Ensure compliance

Roles and Responsibilities: R&D/SRS committee Advises the MCD on the R&D program R&D responsibilities: –M-3, Part 1, Chapter 2 & 3 –Safety of Personnel in Research (1200.8) –Hazardous Agents directive R&D committee may form a Subcommittee on Research Safety (SRS) SRS = Institutional Biosafety Committee (IBC)

SRS/IBC: A Special Issue Research on recombinant DNA & gene transfer –Regulated under NIH Guidelines –Incorporated into VHA policy IBC –Specific membership –Specific responsibilities –Specific requirements www4.od.nih.gov/oba

Roles and Responsibilities: R&D/SRS committee In addition to other responsibilities Ensure biosafety review completed & determines need for changes to protocol Oversee requests for lab registration Reviews requests for: –Lab access & access to BSL-3/SA labs –Purchase transfer or destruction of SA & toxins –Policies & procedures –Results of vulnerability assessments, drills, incidents Document all reviews and findings

Roles and Responsibilities: Biosafety Officer Varies from institution to institution Expertise: science, safety, security, & applicable policies Responsible for or delegates: –Training (delivery & record keeping) –Inventory control –Vulnerability assessments/drills –Ensure compliance POC and resident expert

Roles and Responsibilities: Lab Directors & Investigators Ethical conduct of research Compliance with regulations –Handook1200.8, Directive –Select agents (SA) & toxins –BSL-3 Safety & security within the lab All lab staff –Trained –Work within their scope of work Inventory control

Responsible Official & Alternate Responsible Official Term specific to select agents & toxins regulations (CDC: 42 CFR 73; APHIS: 7 CFR 331, 9 CFR 121) RO = MCD Alternate RO can be the Biosafety Officer, ACOS, AO, other qualified person

Responsible Official (RO) Alternate Responsible Official Approved security risk assessment Ensure facility compliance Alternate RO –Delegated authority from RO –Day to day operations –Knowledgeable (regulations, policy, science) –Coordinate with non-research offices: Human Resources, Police, Safety, etc.

Control of Hazardous Agents: Specific Requirements 1. Controlling lab access 2. Physical security 3. Registering labs for select agent or toxin use 4. Inventory control 5. Emergency preparedness 6. Training 7. Policies and procedures/plans

Controlling Laboratory Access Approve/authorize all staff (paid & WOC) –Approve for all labs HRM “credentialing” OPM background check (SF 85) –Authorize for SA & toxin labs HRM procedures plus Security Risk Assessment (FBI Form FD 961, approval by CDC or USDA) Visitors/visiting scientists, students, etc. escorted at all times unless approved or authorized

Physical Security: A Two Tiered System Laboratories in general –Security is for research area –Individual labs: ordinary locks BSL-3s and labs with SA or toxins –More sophisticated security –Ensures 2 security perimeters –3 rd perimeter: locked refrigerators/cabinets

Physical Security All Laboratories Control access 24/7 Keycard or more sophisticated system that records access Doors self-closing Intrusion alarm integrated into VAMC Video surveillance at entrances suggested Unobstructed view of exterior entrances

Physical Security BSL-3s & Labs with SA or Toxins Security requirements apply to: –BSL-3 without Select Agents or Toxins –BSL-3 with SA or Toxins –Laboratories using SA or T –Storage areas for SA or T

BSL-3s and SA or Toxins Security Requirements Security as required by Select Agents regulations (CDC or APHIS) Cardkey or more sophisticated system –Code/keys specific to the laboratory –Must record entrance & egress Access only to those who work in lab –For SA & toxin labs: Authorized (approved Security Risk Assessment & MCD concurrence) –Special approval: BSL-3 without SA or toxins

BSL-3s and SA or Toxins Security Requirements (cont.) Audible alarms monitored by police Telephone in lab Video surveillance Lock all containers when out of site, not in use Meet requirements in Handbook 0730 “Security and Law Enforcement for: –Windows –Doors –Overhead spaces

Registering Labs for SA or Toxin Use Can NOT begin using SA or toxins unless: –Lab registered –All staff are authorized & have approved SRA Registration by HHS (CDC) or USDA (APHIS) CDC/APHIS inspection of lab

Inventory Control For Hazardous Agents Know: –How much on hand –Where it is –Who has control of it Inventory adjusted when purchased, used, transferred or destroyed. Purchase or store only for active or soon to be active protocols

Emergency Preparedness & Response Plan coordinated with facility & outside officials (Fire, police etc.) Specific to facility & agents in labs Incorporate OSHA, VHA & research requirements Vulnerability assessments & drills annually Document all activities

Training Requirements Integrate Biosafety & Security Applicable regulation (VA, OSHA, CDC) Must occur prior to assignments Annual refresher Generic training Specific to laboratory & agents Maintain good records

Required Policies and Procedures Safety plan Security plan –Physical –Personnel & Access –Cyber –Inventory control Emergency planning & response Training

Policies & Procedures Written & updated as required Implementation must occur Documentation

REVIEW: Control of Hazardous Agents: Specific Requirements 1. Controlling lab access 2. Physical security 3. Registering labs for select agent or toxin use 4. Inventory control 5. Emergency preparedness 6. Training 7. Policies and procedures/plans

Other New Issues BSL-3 Laboratories –Annual Safety & Security visits by ORO –IG remains interested in BSL-3 security –Pans for new or decommissioning BSL-3: call ORD Select Agents or Toxins –Final rule may be out in November –No major changes expected –New SA or Toxin use: report to CO Exempt Quantities of Toxins

Remain under tight security Prevent misuse or theft If not in sight or use must be locked up Accurate inventory Acquisition, transfer, destruction similar to SA & toxins Possess only for specific protocol

Submitting Biosafety Forms: VA Form Required for SRS review Just-in-time document for protocols submitted to CO Problems found: –Not filled out completely –Missing required signatures –Information in form does not match protocol Avoid HOLDS!

Requesting Waivers Waivers only if referenced in VHA policy Rarely given for BSL-3 or SA and toxin lab requirements Request sent to ORD Required information: Directive , Appendix B. Call or if any questions

Remember! Directive as published in November 2002 is still the official policy Information on slides may change once the new draft of this Directive is signed by the Under Secretary for Health Please contact ORD for questions & help –Brenda Cuccherini, Ph.D. (202)